Literature DB >> 3148472

Use of mannitol during neurosurgery: interpatient variability in the plasma and CSF levels.

P Anderson1, L Boréus, E Gordon, M Lagerkranser, A Rudehill, C Lindquist, G Ohman.   

Abstract

An i.v. infusion of mannitol was given over 15 min to 12 patients before they underwent intracranial surgery under general anesthesia. Samples of blood, CSF and urine were taken over 4 h. Mannitol disappeared from plasma in a bi-exponential manner. The mean maximal plasma concentration was 4.08 mg/ml at 15 min, and at 4 h it had declined to 0.53 mg/ml. The mean distribution rate constant was 11.2 h-1, corresponding to a plasma distribution half-life of 0.11 h. The mean elimination rate constant was 0.41 h-1, the plasma half-life was 2.2 h, the central distribution volume was 16.3 l, and total plasma clearance was 100.4 ml/min. The mean concentration of mannitol in CSF during the 4 h period increased up to 0.10 mg/ml. There were marked interindividual differences in the concentration ratio blood/CSF, and the CSF concentration varied 7.5 fold between patients. Optimal use of mannitol during neurosurgery requires further prolonged study of its pharmacokinetics.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3148472     DOI: 10.1007/bf00637601

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  The use of mannitol for the reduction of intracranial pressure in intracranial surgery.

Authors:  H A SHENKIN; B GOLUBOFF; H HAFT
Journal:  J Neurosurg       Date:  1962-10       Impact factor: 5.115

2.  Effect of sodium intake on sodium loss due to mannitol diuresis; an empirical test for renal sodium-retaining activity.

Authors:  D H SIMMONS; R B HARVEY; T HOSHIKO
Journal:  Am J Physiol       Date:  1954-07

3.  Effects of mannitol and steroid therapy on intracranial volume-pressure relationships in patients.

Authors:  J D Miller; P Leech
Journal:  J Neurosurg       Date:  1975-03       Impact factor: 5.115

4.  Mannitol: kinetics of distribution, excretion, and utilization in human beings.

Authors:  R DOMINGUEZ; A C CORCORAN; I H PAGE
Journal:  J Lab Clin Med       Date:  1947-10

5.  Mannitol pharmacokinetics and serum osmolality in dogs and humans.

Authors:  J C Cloyd; B D Snyder; B Cleeremans; S R Bundlie; C H Blomquist; D J Lakatua
Journal:  J Pharmacol Exp Ther       Date:  1986-02       Impact factor: 4.030

6.  Effects of mannitol on blood volume and central hemodynamics in patients undergoing cerebral aneurysm surgery.

Authors:  A Rudehill; M Lagerkranser; C Lindquist; E Gordon
Journal:  Anesth Analg       Date:  1983-10       Impact factor: 5.108

7.  Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients.

Authors:  J P Muizelaar; H A Lutz; D P Becker
Journal:  J Neurosurg       Date:  1984-10       Impact factor: 5.115

8.  Effect of mannitol on increased intracranial pressure.

Authors:  C P McGraw; G Howard
Journal:  Neurosurgery       Date:  1983-09       Impact factor: 4.654

9.  Mannitol infusion. III. The acute effect of the intravenous infusion of mannitol on blood and plasma volumes.

Authors:  K G BARRY; A R BERMAN
Journal:  N Engl J Med       Date:  1961-05-25       Impact factor: 91.245

10.  Evaluation of mannitol for use as a probe marker of gastrointestinal permeability in man.

Authors:  M F Laker; H J Bull; I S Menzies
Journal:  Eur J Clin Invest       Date:  1982-12       Impact factor: 4.686

View more
  5 in total

Review 1.  Osmotic therapy: fact and fiction.

Authors:  Michael N Diringer; Allyson R Zazulia
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 2.  Osmotherapy for elevated intracranial pressure: a critical reappraisal.

Authors:  R Nau
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

3.  Temporary reversal of serum to cerebrospinal fluid glycerol concentration gradient after intravenous infusion of glycerol.

Authors:  R Nau; F J Prins; H Kolenda; H W Prange
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 4.  Hyperosmolar therapy for intracranial hypertension.

Authors:  Andrew Torre-Healy; Nicholas F Marko; Robert J Weil
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

5.  Fluid distribution kinetics during cardiopulmonary bypass.

Authors:  Mattias Törnudd; Robert G Hahn; Joachim H Zdolsek
Journal:  Clinics (Sao Paulo)       Date:  2014-08       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.